SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES

Topical issues of cardiovascular disease pharmacotherapy influencing function of the renin-angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes, angiotensin converting enzyme inhibitors and sartans, are compared. Data from evidence base of the bo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: K. A. Gyamdzhyan, M. L. Maksimov
Formato: Artigo
Idioma:Inglês
Publicado em: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Colecção:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Assuntos:
renin-angiotensin-aldosterone system
sartans
angiotensin converting enzyme inhibitors
pharmacotherapy of cardiovascular diseases
captopril
enalapril
ramipril
losartan
valsartan
irbesartan
endothelial function
atherosclerosis
Acesso em linha:https://www.rpcardio.com/jour/article/view/644
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados